Noor Azri Noor Azerai
KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
’s (MGRC) net profit surged almost 10-fold to RM1.96mil in the third quarter ended March 31 from RM200,000 a year earlier.
The higher profit was led by a higher margin generated by the distribution of immunotherapy and cell therapies.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
